Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Nature Communications
|
February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients
Maria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
Nature Communications
|
June 3, 2018
Recurrent rearrangements of FOS and FOSB define osteoblastoma
Matthew W Fittall, William Mifsud, Nischalan Pillay, et al.
Cancer Cell
|
March 20, 2019
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Christopher D Steele, Maxime Tarabichi, Dahmane Oukrif, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Pan-cancer subclonal mutation analysis of 7,827 tumors predicts clinical outcome
Yujie Jiang, Matthew D Montierth, Kaixian Yu, et al.
Nature
|
June 15, 2022
Signatures of copy number alterations in human cancer
Christopher D Steele, Ammal Abbasi, S M Ashiqul Islam, et al.
Nature
|
March 25, 2021
Breast tumours maintain a reservoir of subclonal diversity during expansion
Darlan C Minussi, Michael D Nicholson, Hanghui Ye, et al.
Nature Cancer
|
November 4, 2021
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Virginia A Turati, José Afonso Guerra-Assunção, Nicola E Potter, et al.
Nature Biotechnology
|
June 11, 2024
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
Adriana Salcedo, Maxime Tarabichi, Alex Buchanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
PRECISE: A prognostic thyrocyte-derived gene signature for papillary thyroid carcinoma
Sophie Li, Chia-Chin Wu, Vicente R Marczyk, et al.
Nature Biotechnology
|
January 11, 2020
A community effort to create standards for evaluating tumor subclonal reconstruction
Adriana Salcedo, Maxime Tarabichi, Shadrielle Melijah G Espiritu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Nature Communications
|
February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients
Maria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
Nature Communications
|
June 3, 2018
Recurrent rearrangements of FOS and FOSB define osteoblastoma
Matthew W Fittall, William Mifsud, Nischalan Pillay, et al.
Cancer Cell
|
March 20, 2019
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Christopher D Steele, Maxime Tarabichi, Dahmane Oukrif, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Pan-cancer subclonal mutation analysis of 7,827 tumors predicts clinical outcome
Yujie Jiang, Matthew D Montierth, Kaixian Yu, et al.
Nature
|
June 15, 2022
Signatures of copy number alterations in human cancer
Christopher D Steele, Ammal Abbasi, S M Ashiqul Islam, et al.
Nature
|
March 25, 2021
Breast tumours maintain a reservoir of subclonal diversity during expansion
Darlan C Minussi, Michael D Nicholson, Hanghui Ye, et al.
Nature Cancer
|
November 4, 2021
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Virginia A Turati, José Afonso Guerra-Assunção, Nicola E Potter, et al.
Nature Biotechnology
|
June 11, 2024
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
Adriana Salcedo, Maxime Tarabichi, Alex Buchanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
PRECISE: A prognostic thyrocyte-derived gene signature for papillary thyroid carcinoma
Sophie Li, Chia-Chin Wu, Vicente R Marczyk, et al.
Nature Biotechnology
|
January 11, 2020
A community effort to create standards for evaluating tumor subclonal reconstruction
Adriana Salcedo, Maxime Tarabichi, Shadrielle Melijah G Espiritu, et al.
Page
of 5